SP
BravenNow
ReNeuron partners with Swansea University on drug delivery research
| USA | economy | ✓ Verified - investing.com

ReNeuron partners with Swansea University on drug delivery research

#ReNeuron #Swansea University #CustomEX platform #drug delivery #strategic collaboration #biotechnology #pharmaceutical research #London

📌 Key Takeaways

  • ReNeuron Group Limited and Swansea University have formed a strategic collaboration
  • The partnership focuses on developing the CustomEX platform as a drug delivery system
  • The announcement was made Monday in London
  • The CustomEX platform will be adapted from stem cell therapies to drug delivery applications
  • This represents an academic-industry partnership in biotechnology research

📖 Full Retelling

ReNeuron Group Limited announced Monday in London a strategic collaboration with Swansea University focused on developing its CustomEX platform as a drug delivery system. This partnership represents a significant milestone for both organizations, combining ReNeuron's proprietary technology with Swansea University's research expertise to advance novel drug delivery solutions. The CustomEX platform, initially developed for stem cell therapies, will now be adapted to potentially improve targeted delivery of therapeutic compounds, which could revolutionize treatment approaches for various medical conditions. The collaboration underscores the growing trend of academic-industry partnerships in biotechnology, where specialized research institutions work alongside commercial entities to translate scientific discoveries into viable medical applications.

🏷️ Themes

Biotechnology partnerships, Drug delivery innovation, Academic-industry collaboration

📚 Related People & Topics

ReNeuron

British stem cell research company

ReNeuron is a UK-based stem cell research company whose shares were listed on the Alternative Investment Market, until it delisted in August 2024 after entering administration. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral art...

View Profile → Wikipedia ↗
Swansea University

Swansea University

Public university in Swansea, Wales, United Kingdom

Swansea University (Welsh: Prifysgol Abertawe) is a public research university located in Swansea, Wales, United Kingdom. It was established as University College of Swansea in 1920, as the fourth college of the University of Wales. In 1996, it changed its name to the University of Wales Swansea fol...

View Profile → Wikipedia ↗
London

London

Capital of England and the United Kingdom

London is the capital and largest city of both England and the United Kingdom, with a population of 9.1 million people in 2024. Its wider metropolitan area is the largest in Western Europe, with a population of 15.1 million. London stands on the River Thames in southeast England, at the head of a 50...

View Profile → Wikipedia ↗

Entity Intersection Graph

No entity connections available yet for this article.

Mentioned Entities

ReNeuron

British stem cell research company

Swansea University

Swansea University

Public university in Swansea, Wales, United Kingdom

London

London

Capital of England and the United Kingdom

}
Original Source
LONDON - ReNeuron Group Limited announced Monday a strategic collaboration with Swansea University focused on developing its CustomEX platform as a drug delivery system, according to a press release statement.
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine